<b>Maternal Health Monitoring Pilot Program established; report.</b> Directs the Department of Health to implement the Maternal Health Monitoring Pilot Program that provides for remote patient monitoring for maternal hypertension and maternal diabetes. The bill requires the Department to select a managed care organization and technology vendor to administer the Pilot Program and to submit a report to the Governor and General Assembly no later than 18 months after the first eligible participant is enrolled in the Pilot Program.
Raw source record
{
"id": 85782,
"url": "https:\/\/www.richmondsunlight.com\/bill\/2026\/sb721\/",
"tags": {
"146298": "health",
"146299": "maternal health",
"146300": "healthcare",
"146301": "pilot program",
"146302": "technology",
"146303": "report",
"146307": "diabetes",
"146308": "hypertension",
"146309": "remote monitoring"
},
"text": [
{
"date": "2026-01-14",
"number": "SB721",
"pdf_url": "https:\/\/downloads.richmondsunlight.com\/bills\/2026\/sb721.pdf"
},
{
"date": "2026-02-06",
"number": "SB721S1"
}
],
"type": "bill",
"year": 2026,
"video": null,
"number": "sb721",
"patron": "Carroll Foy, Jennifer",
"status": "failed committee",
"chamber": "senate",
"changes": null,
"outcome": "failed",
"related": [
{
"id": 84135,
"name": "Appropriations",
"year": 2026,
"count": 4,
"number": "hb335",
"status": "failed committee",
"catch_line": "Independent Pharmacy Access and Resilience Pilot Program; established, report, sunset.",
"date_introduced": "January 11, 2026"
},
{
"id": 84058,
"name": "Education and Health",
"year": 2026,
"count": 3,
"number": "sb168",
"status": "failed committee",
"catch_line": "Certificate of public need; creates exception for maternal and perinatal health services.",
"date_introduced": "January 08, 2026"
},
{
"id": 84631,
"name": "Appropriations",
"year": 2026,
"count": 3,
"number": "hb794",
"status": "signed by governor",
"catch_line": "Drug overdose and drug overdose deaths; VDH to develop plan for opioid overdose response.",
"date_introduced": "January 13, 2026"
},
{
"id": 85959,
"name": null,
"year": 2026,
"count": 3,
"number": "hb1452",
"status": "signed by governor",
"catch_line": "Medicaid; expedited review process for service authorization requests, report.",
"date_introduced": "January 22, 2026"
},
{
"id": 85248,
"name": "Finance",
"year": 2026,
"count": 3,
"number": "sb308",
"status": "signed by governor",
"catch_line": "Drug overdose and drug overdose deaths; VDH to develop plan for opioid overdose response.",
"date_introduced": "January 13, 2026"
}
],
"summary": "<b>Maternal Health Monitoring Pilot Program established; report.<\/b> Directs the Department of Health to implement the Maternal Health Monitoring Pilot Program that provides for remote patient monitoring for maternal hypertension and maternal diabetes. The bill requires the Department to select a managed care organization and technology vendor to administer the Pilot Program and to submit a report to the Governor and General Assembly no later than 18 months after the first eligible participant is enrolled in the Pilot Program.",
"version": "SB721S1",
"copatron": null,
"committee": "Finance",
"full_text": "<p class=enactstm>Be it enacted by the General Assembly of Virginia:<\/p>\n<p class=enactcls>1. That the Code of Virginia is amended by adding in Chapter 10 of Title 32.1 an article numbered 5, consisting of sections numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-331.18\/'>32.1-331.18<\/a> through <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-331.24\/'>32.1-331.24<\/a>, as follows:<\/p>\n<p class=textctr><ins>Article<\/ins><ins> 5<\/ins><ins>.<\/ins><\/p>\n<p class=textctr><ins>Maternal Health Monitoring Pilot Program<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.18<\/ins><ins>. Definitions.<\/ins><\/p>\n<p class=section><ins>As used in this article, unless the context requires a different meaning:<\/ins><\/p>\n<p class=section><ins>\"Depar<\/ins><ins>tment\" means the Department of Medical Assistance Services.<\/ins><\/p>\n<p class=section><ins>\"Eligible participant\" means a patient who is (i) a recipient of medical assistance services<\/ins><ins>,<\/ins><ins> (ii) a member of the participating managed care organization<\/ins><ins>,<\/ins><ins> and <\/ins><ins>(iii) pregnant.<\/ins><\/p>\n<p class=section><ins>\"Escalation pathway\" means an agreement between the participating managed care organizations and the technology vendor on a process to follow when an eligible participant's <\/ins><ins>medical indicators<\/ins><ins> are concerning and warrant further review and investigation.<\/ins><\/p>\n<p class=section><ins>\"Health care provider\" means an obstetrician or maternal fetal medicine physician who is licensed in the Commonwealth and caring for an eligible patient during pregnancy.<\/ins><\/p>\n<p class=section><ins>\"Participating managed care organization\" means the managed care organization selected by the Department to administer the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram.<\/ins><\/p>\n<p class=section><ins>\"Pilot <\/ins><ins>P<\/ins><ins>rogram\" means the Maternal Health Monitoring Pilot Program<\/ins><ins> established <\/ins><ins>pursuant to <\/ins><ins>this article<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>\"Remote monitoring clinical care team\" means a team <\/ins><ins>co<\/ins><ins>nsisting<\/ins><ins> of nurses licensed in the Commonwealth, dietitians, and certified diabetes care and education specialists that monitor eligible participants' <\/ins><ins>medical indicators<\/ins><ins> and<\/ins><ins> provide nutrition<\/ins><ins> guidance, diabetes and hypertension management counseling, and pregnancy and postpartum advice.<\/ins><ins> <\/ins><\/p>\n<p class=section><ins>\"<\/ins><ins>Technology vendor\" means the technology company selected by the Department to contract with the participating managed care organization in administering the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.19<\/ins><ins>. Establishment<\/ins><ins> and administration<\/ins><ins> of <\/ins><ins>Maternal Health Monitoring Pilot Program.<\/ins><\/p>\n<p class=section><ins>A. <\/ins><ins>For fiscal years 2027 and 2028, the<\/ins><ins> Maternal Health Monitoring P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram is established within the Department to offer eligible participants improved maternal health care through remote patient monitoring for maternal hypertension and maternal diabetes.<\/ins><\/p>\n<p class=section><ins>B. <\/ins><ins>The Department shall select <\/ins><ins>one or more<\/ins><ins> managed care organization<\/ins><ins>s<\/ins><ins> and <\/ins><ins>one<\/ins><ins> <\/ins><ins>technology vendor to administer the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins> in a manner determined by the Department. For the purpose of administering the<\/ins><ins> <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>, the participating managed care organization<\/ins><ins>s<\/ins><ins> shall contract directly with <\/ins><ins>the<\/ins><ins> technology vendor to offer remote patient monitoring for maternal hypertension and maternal diabetes<\/ins><ins> and ensure that eligible participants have access to th<\/ins><ins>e <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.20<\/ins><ins>. Remote patient monitoring for maternal hypertension and maternal diabetes.<\/ins><\/p>\n<p class=section><ins>A. Technology for remote patient monitoring for maternal hypertension and maternal diabetes provided by the technology vendor shall:<\/ins><\/p>\n<p class=section><ins>1. Collect health data from an eligible participant and electronically <\/ins><ins>transmit<\/ins><ins> <\/ins><ins>that information securely for interpretation by a health care provider;<\/ins><\/p>\n<p class=section><ins>2. Be authorized by the U<\/ins><ins>.<\/ins><ins>S<\/ins><ins>.<\/ins><ins> Food and Drug Administration;<\/ins><\/p>\n<p class=section><ins>3. Monitor health data, including blood pressure, weight, blood glucose levels, or other physiological health data <\/ins><ins>as determined by the eligible participant's health care provider;<\/ins><\/p>\n<p class=section><ins>4. Be capable of transmitting health data through cellular networks<\/ins><ins>;<\/ins><ins> and<\/ins><\/p>\n<p class=section><ins>5. Be pre-programmed specifically for each eligible participant so that it works directly out-of-the-box for that specific eligible participant.<\/ins><\/p>\n<p class=section><ins>B. The technology vendor shall<\/ins><ins> ensure that<\/ins><ins>:<\/ins><\/p>\n<p class=section><ins>1. <\/ins><ins>R<\/ins><ins>emote patient monitoring for maternal hypertension and maternal diabetes is possible<\/ins><ins> during pregnancy and<\/ins><ins> for up to three months postpartum;<\/ins><\/p>\n<p class=section><ins>2. Remote patient monitoring devices are <\/ins><ins>provided and <\/ins><ins>delivered to <\/ins><ins>each<\/ins><ins> eligible participant;<\/ins><ins> and<\/ins><\/p>\n<p class=section><ins>3. The eligible participant has a process to be trained on use of the remote patient monitoring devices.<\/ins><\/p>\n<p class=section><ins>C. The technology vendor shall <\/ins><ins>ensure that the remote monitoring clinical care team<\/ins><ins> is<\/ins><ins> <\/ins><ins>capable of:<\/ins><\/p>\n<p class=section><ins>1. Monitoring and reviewing eligible participants' health data;<\/ins><\/p>\n<p class=section><ins>2. Creating an escalation pathway with an eligible participant's<\/ins><ins> participating managed care organization and<\/ins><ins> health care provider if the eligible participant's remote patient monitoring readings, in conjunction with the eligible participant's symptoms, require immediate attention from the eligible participant's health care provider as determined by clinical practice guidelines;<\/ins><\/p>\n<p class=section><ins>3. Providing health coaching to participants, including nutrition, condition management, and healthy behavior modification<\/ins><ins>; and<\/ins><\/p>\n<p class=section><ins>4. Coordinating with the elig<\/ins><ins>ible participant's health care provider as needed.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.21<\/ins><ins>. Eligible <\/ins><ins>localities<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>The Department shall implement the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins> in as many <\/ins><ins>localities<\/ins><ins> as necessary to ensure participation of <\/ins><ins>up to 500<\/ins><ins> eligible participants. The participating managed care organization shall ensure that eligible participants in the <\/ins><ins>localities<\/ins><ins> selected by the Department have access to the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.22<\/ins><ins>. Fee payment for administration of <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>A. The Department shall pay a fee <\/ins><ins>of no more than $500,000 <\/ins><ins>to participating managed care organization<\/ins><ins>s<\/ins><ins> to administer the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>B. The participating managed care organization shall use the fee paid pursuant to subsection A to cover the costs of<\/ins><ins> c<\/ins><ins>ontracting with the technology vendor<\/ins><ins> and a<\/ins><ins>dministrating the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.23<\/ins><ins>. Operation of <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>The Department shall ensure that the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins> has<\/ins><ins> up to 500<\/ins><ins> eligible participants. The <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins> shall be operational no later than 180 days after the contract date between the participating managed care organization and the technology vendor.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.24<\/ins><ins>. Report.<\/ins><\/p>\n<p class=section><ins>A. <\/ins><ins>No later than 18 months after the first eligible participant is enrolled in the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>, the Department shall <\/ins><ins>collaborate <\/ins><ins>with participating managed care organizations and other relevant stakeholders to develop a report evaluating the outcomes of the Pilot Program<\/ins><ins>,<\/ins><ins> including recommendations regarding whether the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins> should be expanded throughout the <\/ins><ins>Commonwealth. <\/ins><\/p>\n<p class=section><ins>B. The report shall evaluate claims data, vital stats data,<\/ins><ins> and E<\/ins><ins>H<\/ins><ins>R\/EMR data <\/ins><ins>of participants <\/ins><ins>to determine the Pilot Program's impact on the following maternal, fetal, and neonatal health outcomes and evaluate whether the Pilot Program improves <\/ins><ins>those outcomes while reducing Medicaid costs:<\/ins><\/p>\n<p class=section><ins>1. Maternal outcomes:<\/ins><\/p>\n<p class=section><ins>a. Maternal mortality rate;<\/ins><\/p>\n<p class=section><ins>b. Severe maternal morbidity rate;<\/ins><\/p>\n<p class=section><ins>c. Preeclampsia;<\/ins><\/p>\n<p class=section><ins>d. C-section rate;<\/ins><\/p>\n<p class=section><ins>e. Mean length of hospital stay;<\/ins><\/p>\n<p class=section><ins>f. ICU admission rate;<\/ins><\/p>\n<p class=section><ins>g. <\/ins><ins>Mean length of ICU stay;<\/ins><ins> and<\/ins><\/p>\n<p class=section><ins>h. Postpartum hospital readmission rate.<\/ins><\/p>\n<p class=section><ins>2. Fetal and neonatal outcomes:<\/ins><\/p>\n<p class=section><ins>a. Fetal mortality rate;<\/ins><\/p>\n<p class=section><ins>b. Fetal growth restriction;<\/ins><\/p>\n<p class=section><ins>c. Neonatal mortality rate;<\/ins><\/p>\n<p class=section><ins>d. NICU admission rate;<\/ins><\/p>\n<p class=section><ins>e. Mean length of NICU stay;<\/ins><\/p>\n<p class=section><ins>f. Neonatal hypoglycemia;<\/ins><\/p>\n<p class=section><ins>g. Preterm birth rate;<\/ins><\/p>\n<p class=section><ins>h. Gestational age at delivery;<\/ins><ins> and<\/ins><\/p>\n<p class=section><ins>i. Birthweight.<\/ins><\/p>\n<p class=section><ins>C. <\/ins><ins>The Department shall submit the report to:<\/ins><\/p>\n<p class=section><ins>1. The Governor;<\/ins><\/p>\n<p class=section><ins>2. The Chair of the Senate Committee on Finance and Appropriations;<\/ins><\/p>\n<p class=section><ins>3. The Chair of the House Committee on Appropriations;<\/ins><\/p>\n<p class=section><ins>4. The Chair of the Senate<\/ins><ins> Committee on<\/ins><ins> Education and Health; and<\/ins><\/p>\n<p class=section><ins>5. The Chair of the House Committee on Health and Human Services.<\/ins><\/p>",
"catch_line": "Maternal Health Monitoring Pilot Program; established, report.",
"duplicates": [
{
"year": 2027,
"number": "sb721",
"patron": "Carroll Foy, Jennifer",
"status": "in committee",
"chamber": "senate",
"catch_line": "Maternal Health Monitoring Pilot Program; established, report.",
"date_introduced": "2026-01-14"
}
],
"session_id": 32,
"word_count": 1870,
"patron_party": "D",
"patron_place": "Woodbridge",
"summary_hash": "66504fba4fcf8bed3ebfa442c215dd54",
"patron_prefix": "Del.",
"patron_suffix": "(D-Woodbridge)",
"status_detail": "failed committee",
"_rsun_versions": [
{
"id": "452ee242fefda3ac01353336fe7e9e4e51bd33b265211b006080076f450d07e1",
"code": "SB721S1",
"bill_id": 85782,
"source_url": null,
"source_date": "2026-02-06",
"source_hash": "308fe7301e869a8032fb1df51f37f04c168dc374ce02d74995d5cc17e83515f4",
"source_html": "<p class=enactstm>Be it enacted by the General Assembly of Virginia:<\/p>\n<p class=enactcls>1. That the Code of Virginia is amended by adding in Chapter 10 of Title 32.1 an article numbered 5, consisting of sections numbered <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-331.18\/'>32.1-331.18<\/a> through <a href='https:\/\/law.lis.virginia.gov\/vacode\/32.1-331.24\/'>32.1-331.24<\/a>, as follows:<\/p>\n<p class=textctr><ins>Article<\/ins><ins> 5<\/ins><ins>.<\/ins><\/p>\n<p class=textctr><ins>Maternal Health Monitoring Pilot Program<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.18<\/ins><ins>. Definitions.<\/ins><\/p>\n<p class=section><ins>As used in this article, unless the context requires a different meaning:<\/ins><\/p>\n<p class=section><ins>\"Depar<\/ins><ins>tment\" means the Department of Medical Assistance Services.<\/ins><\/p>\n<p class=section><ins>\"Eligible participant\" means a patient who is (i) a recipient of medical assistance services<\/ins><ins>,<\/ins><ins> (ii) a member of the participating managed care organization<\/ins><ins>,<\/ins><ins> and <\/ins><ins>(iii) pregnant.<\/ins><\/p>\n<p class=section><ins>\"Escalation pathway\" means an agreement between the participating managed care organizations and the technology vendor on a process to follow when an eligible participant's <\/ins><ins>medical indicators<\/ins><ins> are concerning and warrant further review and investigation.<\/ins><\/p>\n<p class=section><ins>\"Health care provider\" means an obstetrician or maternal fetal medicine physician who is licensed in the Commonwealth and caring for an eligible patient during pregnancy.<\/ins><\/p>\n<p class=section><ins>\"Participating managed care organization\" means the managed care organization selected by the Department to administer the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram.<\/ins><\/p>\n<p class=section><ins>\"Pilot <\/ins><ins>P<\/ins><ins>rogram\" means the Maternal Health Monitoring Pilot Program<\/ins><ins> established <\/ins><ins>pursuant to <\/ins><ins>this article<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>\"Remote monitoring clinical care team\" means a team <\/ins><ins>co<\/ins><ins>nsisting<\/ins><ins> of nurses licensed in the Commonwealth, dietitians, and certified diabetes care and education specialists that monitor eligible participants' <\/ins><ins>medical indicators<\/ins><ins> and<\/ins><ins> provide nutrition<\/ins><ins> guidance, diabetes and hypertension management counseling, and pregnancy and postpartum advice.<\/ins><ins> <\/ins><\/p>\n<p class=section><ins>\"<\/ins><ins>Technology vendor\" means the technology company selected by the Department to contract with the participating managed care organization in administering the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.19<\/ins><ins>. Establishment<\/ins><ins> and administration<\/ins><ins> of <\/ins><ins>Maternal Health Monitoring Pilot Program.<\/ins><\/p>\n<p class=section><ins>A. <\/ins><ins>For fiscal years 2027 and 2028, the<\/ins><ins> Maternal Health Monitoring P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram is established within the Department to offer eligible participants improved maternal health care through remote patient monitoring for maternal hypertension and maternal diabetes.<\/ins><\/p>\n<p class=section><ins>B. <\/ins><ins>The Department shall select <\/ins><ins>one or more<\/ins><ins> managed care organization<\/ins><ins>s<\/ins><ins> and <\/ins><ins>one<\/ins><ins> <\/ins><ins>technology vendor to administer the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins> in a manner determined by the Department. For the purpose of administering the<\/ins><ins> <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>, the participating managed care organization<\/ins><ins>s<\/ins><ins> shall contract directly with <\/ins><ins>the<\/ins><ins> technology vendor to offer remote patient monitoring for maternal hypertension and maternal diabetes<\/ins><ins> and ensure that eligible participants have access to th<\/ins><ins>e <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.20<\/ins><ins>. Remote patient monitoring for maternal hypertension and maternal diabetes.<\/ins><\/p>\n<p class=section><ins>A. Technology for remote patient monitoring for maternal hypertension and maternal diabetes provided by the technology vendor shall:<\/ins><\/p>\n<p class=section><ins>1. Collect health data from an eligible participant and electronically <\/ins><ins>transmit<\/ins><ins> <\/ins><ins>that information securely for interpretation by a health care provider;<\/ins><\/p>\n<p class=section><ins>2. Be authorized by the U<\/ins><ins>.<\/ins><ins>S<\/ins><ins>.<\/ins><ins> Food and Drug Administration;<\/ins><\/p>\n<p class=section><ins>3. Monitor health data, including blood pressure, weight, blood glucose levels, or other physiological health data <\/ins><ins>as determined by the eligible participant's health care provider;<\/ins><\/p>\n<p class=section><ins>4. Be capable of transmitting health data through cellular networks<\/ins><ins>;<\/ins><ins> and<\/ins><\/p>\n<p class=section><ins>5. Be pre-programmed specifically for each eligible participant so that it works directly out-of-the-box for that specific eligible participant.<\/ins><\/p>\n<p class=section><ins>B. The technology vendor shall<\/ins><ins> ensure that<\/ins><ins>:<\/ins><\/p>\n<p class=section><ins>1. <\/ins><ins>R<\/ins><ins>emote patient monitoring for maternal hypertension and maternal diabetes is possible<\/ins><ins> during pregnancy and<\/ins><ins> for up to three months postpartum;<\/ins><\/p>\n<p class=section><ins>2. Remote patient monitoring devices are <\/ins><ins>provided and <\/ins><ins>delivered to <\/ins><ins>each<\/ins><ins> eligible participant;<\/ins><ins> and<\/ins><\/p>\n<p class=section><ins>3. The eligible participant has a process to be trained on use of the remote patient monitoring devices.<\/ins><\/p>\n<p class=section><ins>C. The technology vendor shall <\/ins><ins>ensure that the remote monitoring clinical care team<\/ins><ins> is<\/ins><ins> <\/ins><ins>capable of:<\/ins><\/p>\n<p class=section><ins>1. Monitoring and reviewing eligible participants' health data;<\/ins><\/p>\n<p class=section><ins>2. Creating an escalation pathway with an eligible participant's<\/ins><ins> participating managed care organization and<\/ins><ins> health care provider if the eligible participant's remote patient monitoring readings, in conjunction with the eligible participant's symptoms, require immediate attention from the eligible participant's health care provider as determined by clinical practice guidelines;<\/ins><\/p>\n<p class=section><ins>3. Providing health coaching to participants, including nutrition, condition management, and healthy behavior modification<\/ins><ins>; and<\/ins><\/p>\n<p class=section><ins>4. Coordinating with the elig<\/ins><ins>ible participant's health care provider as needed.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.21<\/ins><ins>. Eligible <\/ins><ins>localities<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>The Department shall implement the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins> in as many <\/ins><ins>localities<\/ins><ins> as necessary to ensure participation of <\/ins><ins>up to 500<\/ins><ins> eligible participants. The participating managed care organization shall ensure that eligible participants in the <\/ins><ins>localities<\/ins><ins> selected by the Department have access to the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.22<\/ins><ins>. Fee payment for administration of <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>A. The Department shall pay a fee <\/ins><ins>of no more than $500,000 <\/ins><ins>to participating managed care organization<\/ins><ins>s<\/ins><ins> to administer the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>B. The participating managed care organization shall use the fee paid pursuant to subsection A to cover the costs of<\/ins><ins> c<\/ins><ins>ontracting with the technology vendor<\/ins><ins> and a<\/ins><ins>dministrating the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.23<\/ins><ins>. Operation of <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>.<\/ins><\/p>\n<p class=section><ins>The Department shall ensure that the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins> has<\/ins><ins> up to 500<\/ins><ins> eligible participants. The <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins> shall be operational no later than 180 days after the contract date between the participating managed care organization and the technology vendor.<\/ins><\/p>\n<p class=catchln><ins>\u00a7 32.1-<\/ins><ins>331.24<\/ins><ins>. Report.<\/ins><\/p>\n<p class=section><ins>A. <\/ins><ins>No later than 18 months after the first eligible participant is enrolled in the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins>, the Department shall <\/ins><ins>collaborate <\/ins><ins>with participating managed care organizations and other relevant stakeholders to develop a report evaluating the outcomes of the Pilot Program<\/ins><ins>,<\/ins><ins> including recommendations regarding whether the <\/ins><ins>P<\/ins><ins>ilot <\/ins><ins>P<\/ins><ins>rogram<\/ins><ins> should be expanded throughout the <\/ins><ins>Commonwealth. <\/ins><\/p>\n<p class=section><ins>B. The report shall evaluate claims data, vital stats data,<\/ins><ins> and E<\/ins><ins>H<\/ins><ins>R\/EMR data <\/ins><ins>of participants <\/ins><ins>to determine the Pilot Program's impact on the following maternal, fetal, and neonatal health outcomes and evaluate whether the Pilot Program improves <\/ins><ins>those outcomes while reducing Medicaid costs:<\/ins><\/p>\n<p class=section><ins>1. Maternal outcomes:<\/ins><\/p>\n<p class=section><ins>a. Maternal mortality rate;<\/ins><\/p>\n<p class=section><ins>b. Severe maternal morbidity rate;<\/ins><\/p>\n<p class=section><ins>c. Preeclampsia;<\/ins><\/p>\n<p class=section><ins>d. C-section rate;<\/ins><\/p>\n<p class=section><ins>e. Mean length of hospital stay;<\/ins><\/p>\n<p class=section><ins>f. ICU admission rate;<\/ins><\/p>\n<p class=section><ins>g. <\/ins><ins>Mean length of ICU stay;<\/ins><ins> and<\/ins><\/p>\n<p class=section><ins>h. Postpartum hospital readmission rate.<\/ins><\/p>\n<p class=section><ins>2. Fetal and neonatal outcomes:<\/ins><\/p>\n<p class=section><ins>a. Fetal mortality rate;<\/ins><\/p>\n<p class=section><ins>b. Fetal growth restriction;<\/ins><\/p>\n<p class=section><ins>c. Neonatal mortality rate;<\/ins><\/p>\n<p class=section><ins>d. NICU admission rate;<\/ins><\/p>\n<p class=section><ins>e. Mean length of NICU stay;<\/ins><\/p>\n<p class=section><ins>f. Neonatal hypoglycemia;<\/ins><\/p>\n<p class=section><ins>g. Preterm birth rate;<\/ins><\/p>\n<p class=section><ins>h. Gestational age at delivery;<\/ins><ins> and<\/ins><\/p>\n<p class=section><ins>i. Birthweight.<\/ins><\/p>\n<p class=section><ins>C. <\/ins><ins>The Department shall submit the report to:<\/ins><\/p>\n<p class=section><ins>1. The Governor;<\/ins><\/p>\n<p class=section><ins>2. The Chair of the Senate Committee on Finance and Appropriations;<\/ins><\/p>\n<p class=section><ins>3. The Chair of the House Committee on Appropriations;<\/ins><\/p>\n<p class=section><ins>4. The Chair of the Senate<\/ins><ins> Committee on<\/ins><ins> Education and Health; and<\/ins><\/p>\n<p class=section><ins>5. The Chair of the House Committee on Health and Human Services.<\/ins><\/p>",
"source_metadata": {
"bodyAssociation": "archive-reported-current-version",
"archiveReference": {
"date": "2026-02-06",
"number": "SB721S1"
}
}
}
],
"copatron_count": 0,
"patron_address": [
"P.O. Box 5113",
"Woodbridge",
"VA 22194"
],
"patron_chamber": "house",
"patron_started": 2018,
"session_lis_id": 261,
"status_history": [
{
"date": "02\/12\/2026",
"status": "Continued to 2027 in Finance and Appropriations (13-Y 0-N)",
"date_raw": "2026-02-12",
"vote_count": null,
"lis_vote_id": "297056",
"translation": "failed committee"
},
{
"date": "02\/12\/2026",
"status": "Continued to 2027 in Finance and Appropriations",
"date_raw": "2026-02-12",
"vote_count": null,
"lis_vote_id": "297056",
"translation": "failed committee"
},
{
"date": "02\/09\/2026",
"status": "Fiscal Impact Statement from Department of Planning and Budget (SB721)",
"date_raw": "2026-02-09",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/06\/2026",
"status": "Committee substitute printed 26107023D-S1",
"date_raw": "2026-02-06",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/05\/2026",
"status": "Reported from Education and Health with substitute and rereferred to Finance and Appropriations (15-Y 0-N)",
"date_raw": "2026-02-05",
"vote_count": null,
"lis_vote_id": "294738",
"translation": "passed committee"
},
{
"date": "02\/05\/2026",
"status": "Reported from Education and Health with substitute and rereferred to Finance and Appropriations",
"date_raw": "2026-02-05",
"vote_count": null,
"lis_vote_id": null,
"translation": "passed committee"
},
{
"date": "02\/03\/2026",
"status": "Senate subcommittee offered",
"date_raw": "2026-02-03",
"vote_count": null,
"lis_vote_id": null,
"translation": null
},
{
"date": "02\/03\/2026",
"status": "Assigned Education sub: Health",
"date_raw": "2026-02-03",
"vote_count": null,
"lis_vote_id": null,
"translation": "in subcommittee"
},
{
"date": "01\/14\/2026",
"status": "Referred to Committee on Education and Health",
"date_raw": "2026-01-14",
"vote_count": null,
"lis_vote_id": null,
"translation": "in committee"
},
{
"date": "01\/14\/2026",
"status": "Presented and ordered printed 26102835D",
"date_raw": "2026-01-14",
"vote_count": null,
"lis_vote_id": null,
"translation": "introduced"
}
],
"chief_patron_id": 423,
"date_introduced": "2026-01-14",
"patron_district": 2,
"patron_shortname": "jcarrollfoy",
"committee_chamber": "senate",
"status_detail_date": "02\/12\/2026",
"committee_shortname": "finance",
"patron_name_formatted": "Del. Jennifer Carroll Foy (D-Woodbridge)"
}